drugset / Trial / NCT04883619
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active Lupus Nephritis (LN).
Timeline
- Start
- 2026-01-15
- Primary completion
- 2028-02-28
- Completion
- 2028-02-28
Outcome
Outcome not reported
Stopped (Business): “Business Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nipocalimab | Monoclonal antibody | — | Intravenous |
| Background | Mycophenolate Mofetil | Small molecule | — | Intravenous |
| Background | mycophenolic acid | Small molecule | — | Intravenous |